IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Today’s Receipts
Public-record receiptD-CASource pending

Gilbert Cisneros disclosed BUY $PFE

Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.

Trade range
$1K – $15K
Filed
2025-06-09
Trade date
2025-05-30
Disclosure lag
10 days after trade

Why this receipt matters

A quick read before you share it.

These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.

Source pending
1The disclosure is tracked with source status pending, so treat it as a record to verify rather than a finished source trail.
2The filing appeared 10 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $1K – $15K, which is the public reporting band rather than an exact profit or loss figure.
413 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Gilbert Cisneros, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 27 lobbying filings.

Source

source pending
Source: indexed congressional disclosure; official source link pending · filed 2025-06-09 · disclosed 10d after transaction

Market context

Pfizer Inc.

Sector: Healthcare

Factual flags

  • 27 lobbying filings linked to this ticker.
  • 13 nearby same-ticker disclosures in the surrounding 30-day window.
  • 47 trades filed on 2025-06-09 (batch dump)
  • 4 members traded PFE within 7 days (starting 2025-05-28)

Member trail

Gilbert Cisneros

U.S. House · CA-31

House Committee on Armed ServicesHouse Committee on Small Business

Ticker trail

$PFE

Pfizer Inc.

Follow this ticker

Alert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.